The Synergistic Inhibition of IRF4/NF-κB/STAT3 Pathway by Lenalidomide Combined with BTK Inhibitor Enhances the Effect of Rituximab on Apoptosis in ABC Type Diffuse Large B-cell Lymphoma
AIM: Activated B-cell like diffuse large B-cell lymphoma (ABC-DLBCL) has poor response to standard rituximab combined chemotherapy regimen and poor clinical prognosis. The aim of this study is to investigate the in vitro experimental basis for the clinical application of the three-drug combination (Zanubrutinib, Lenali...